Evidence map›Paper›PMID 36689081›Full record

ArticleTranslational stroke research2024

Exercise Improves Cerebral Blood Flow and Functional Outcomes in an Experimental Mouse Model of Vascular Cognitive Impairment and Dementia (VCID).

Mohammad Badruzzaman Khan, Haroon Alam, Shahneela Siddiqui, Muhammad Fasih Shaikh, Abhinav Sharma, Amna Rehman, Babak Baban, Ali S Arbab, David C Hess

Open access · greenAbstract read
In one paragraph

Article in Translational stroke research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mohammad Badruzzaman KhanDepartment of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA. mkhan@augusta.edu.
Haroon Alam *Department of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Shahneela Siddiqui *Department of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Muhammad Fasih ShaikhDepartment of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Abhinav SharmaDepartment of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Amna RehmanDepartment of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Babak BabanDepartment of Oral Biology, Dental College of Georgia, Augusta University, Augusta, GA, 30912, USA.
Ali S ArbabGeorgia Cancer Center, Augusta University, Augusta, GA, 30912, USA.
David C HessDepartment of Neurology, Medical College of Georgia, Augusta University, 1120 15thStreet, CA 1053, Augusta, GA, 30912, USA.
Augusta University · USAugusta University Health · US

Funding

Targeting RBC dysfunction in VCIDRF1NS122863 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2021 to 2021
$1.6M
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID ModelR01NS099455 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2017 to 2020
$1.5M
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)R01NS112511 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2020 to 2023
$1.3M
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectantU01NS113356 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2019 to 2021
$1.1M
Targeting RBC dysfunction in VCIDR01NS122863 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2024 to 2025
$1.0M
NIH HHS R01 NS099455, 1U01Ns113356, and R01 NS112511NINDS NIH HHS R01 NS099455NINDS NIH HHS R01 NS112511NINDS NIH HHS R01 NS122863NINDS NIH HHS RF1 NS122863NINDS NIH HHS U01 NS113356
6 · The paper itself

Abstract

Vascular cognitive impairment and dementia (VCID) are a growing threat to public health without any known treatment. The bilateral common carotid artery stenosis (BCAS) mouse model is valid for VCID. Previously, we have reported that remote ischemic postconditioning (RIPostC) during chronic cerebral hypoperfusion (CCH) induced by BCAS increases cerebral blood flow (CBF), improves cognitive function, and reduces white matter damage. We hypothesized that physical exercise (EXR) would augment CBF during CCH and prevent cognitive impairment in the BCAS model. BCAS was performed in C57/B6 mice of both sexes to establish CCH. One week after the BCAS surgery, mice were randomized to treadmill exercise once daily or no EXR for four weeks. CBF was monitored with an LSCI pre-, post, and 4 weeks post-BCAS. Cognitive testing was performed for post-BCAS after exercise training, and brain tissue was harvested for histopathology and biochemical test. BCAS led to chronic hypoperfusion resulting in impaired cognitive function and other functional outcomes. Histological examination revealed that BCAS caused changes in neuronal morphology and cell death in the cortex and hippocampus. Immunoblotting showed that BCAS was associated with a significant downregulate of AMPK and pAMPK and NOS3 and pNOS3. BCAS also decreased red blood cell (RBC) deformability. EXR therapy increased and sustained improved CBF and cognitive function, muscular strength, reduced cell death, and loss of white matter. EXR is effective in the BCAS model, improving CBF and cognitive function, reducing white matter damage, improving RBC deformability, and increasing RBC NOS3 and AMPK. The mechanisms by which EXR improves CBF and attenuates tissue damage need further investigation.

Indexed as

Brain IschemiaCognitive DysfunctionDementia, VascularAMP-Activated Protein KinasesAnimalsCerebrovascular CirculationDisease Models, AnimalMiceAMP-Activated Protein KinasesAMPKChronic cerebral hypoperfusionExercise (EXR), Cerebral blood flow (CBF)Neurobehavioral testPhospho-AMPKp-NOS3RBC deformability, White matter (WM) degeneration, Nitric oxide synthase (NOS3)Vascular cognitive impairment and dementia (VCID)

Identifiers

PMID36689081
PMCPMC10363247
OpenAlexW4317727255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.